Yulia Weissman

Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study

A. Oliver, L. Leibovici, D. Paterson, 2022, Infectious Disease and Therapy.

Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia - retrospective multicenter study.

A. Oliver, L. Leibovici, D. Paterson, 2019, International journal of antimicrobial agents.

Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.

A. Oliver, L. Leibovici, D. Paterson, 2021, The Journal of antimicrobial chemotherapy.

Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study

A. Oliver, D. Yahav, E. Gonzalez-Barbera, 2022, Infection.

Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study.

A. Oliver, L. Leibovici, D. Paterson, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.